Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor

Author： Bladbjerg E.M.  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.17, Iss.12, 2002-12, pp. : 3235-3241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BINDING OF TISSUE FACTOR PATHWAY INHIBITOR TO CULTURED ENDOTHELIAL CELLS-INFLUENCE OF GLYCOSAMINOGLYCANS - VII: Additional pathway initiating blood coagulation

By Iversen N.   Sandset P.M.   Abildgaard U.   Torjesen P.A.  

Thrombosis Research, Vol. 84, Iss. 4, 1996-11 ,pp. : 267-278

Elsevier

Access to resources Recommend Favorite

Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI

By Erem Cihangir  

Endocrine Journal, Vol. 33, Iss. 3, 2008-06 ,pp. : 270-276

Humana Press, Inc

Access to resources Recommend Favorite

Inhibition of the Tissue Factor Coagulation Pathway

By  

Current Vascular Pharmacology, Vol. 2, Iss. 4, 2004-10 ,pp. : 319-327

Bentham Science Publishers

Access to resources Recommend Favorite

Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor

By Takahashi H.   Sato N.   Shibata A.  

Thrombosis Research, Vol. 80, Iss. 4, 1995-11 ,pp. : 339-348

Elsevier

Access to resources Recommend Favorite

The inhibitors of the tissue factor:factor VII pathway

By Golino P.  

Thrombosis Research, Vol. 106, Iss. 3, 2002-05 ,pp. : 257-265

Elsevier

Access to resources Recommend Favorite